{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T10:00:21Z","timestamp":1781085621052,"version":"3.54.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T00:00:00Z","timestamp":1674000000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.seizure.2023.01.008","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T05:47:06Z","timestamp":1673588826000},"page":"56-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Adaptive behaviour in children exposed to topiramate in the womb: An observational cohort study"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0053-0063","authenticated-orcid":false,"given":"R.","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Wittkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-0917","authenticated-orcid":false,"given":"R.L.","family":"Bromley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2023.01.008_bib0001","unstructured":"National, I., for, Health, and, Care, Excellence, (NICE), Epilepsies: diagnosis and management (updated NICE clinical guideline CG137). 2020. https:\/\/www.nice.org.uk\/guidance\/cg137."},{"key":"10.1016\/j.seizure.2023.01.008_bib0002","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","volume":"10","author":"Bromley","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.seizure.2023.01.008_bib0003","article-title":"Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child","volume":"11","author":"Weston","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.seizure.2023.01.008_bib0004","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1212\/01.wnl.0000318293.28278.33","article-title":"Topiramate in pregnancy: preliminary experience from the UK epilepsy and pregnancy register","volume":"71","author":"Hunt","year":"2008","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.seizure.2023.01.008_bib0005","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ajog.2012.07.008","article-title":"Use of topiramate in pregnancy and risk of oral clefts","volume":"207","author":"Margulis","year":"2012","journal-title":"Am J Obstet Gynecol"},{"issue":"21","key":"10.1016\/j.seizure.2023.01.008_bib0006","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/WNL.0b013e3182574f39","article-title":"Comparative safety of antiepileptic drugs during pregnancy","volume":"78","author":"Hernandez-Diaz","year":"2012","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.seizure.2023.01.008_bib0007","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00415-013-7239-x","article-title":"Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy","volume":"261","author":"Veiby","year":"2014","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.seizure.2023.01.008_bib0008","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/ana.25031","article-title":"Fetal growth and premature delivery in pregnant women on antiepileptic drugs","volume":"82","author":"Hernandez-Diaz","year":"2017","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2023.01.008_bib0009","doi-asserted-by":"crossref","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of prenatal exposure to antiseizure medication with risk of autism and intellectual disability","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol"},{"issue":"12","key":"10.1016\/j.seizure.2023.01.008_bib0010","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1136\/jnnp-2018-318386","article-title":"In utero exposure to antiepileptic drugs is associated with learning disabilities among offspring","volume":"89","author":"Bech","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"18","key":"10.1016\/j.seizure.2023.01.008_bib0011","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1212\/WNL.0000000000003157","article-title":"Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate","volume":"87","author":"Bromley","year":"2016","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.seizure.2023.01.008_bib0012","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.reprotox.2012.05.038","article-title":"Preliminary findings of the developmental effects of in utero exposure to topiramate","volume":"34","author":"Rihtman","year":"2012","journal-title":"Reprod Toxicol"},{"issue":"9","key":"10.1016\/j.seizure.2023.01.008_bib0013","doi-asserted-by":"crossref","first-page":"e811","DOI":"10.1212\/WNL.0000000000006073","article-title":"Verbal abilities in children of mothers with epilepsy: association to maternal folate status","volume":"91","author":"Husebye","year":"2018","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.seizure.2023.01.008_bib0014","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamaneurol.2017.3897","article-title":"Association of folic acid supplementation during pregnancy with the risk of autistic traits in children exposed to antiepileptic drugs in utero","volume":"75","author":"Bjork","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.seizure.2023.01.008_bib0015","series-title":"Vineland adaptive behavior scales","author":"Cicchetti","year":"2016"},{"issue":"2","key":"10.1016\/j.seizure.2023.01.008_bib0016","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/jnnp.2005.074203","article-title":"Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK epilepsy and pregnancy register","volume":"77","author":"Morrow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.seizure.2023.01.008_bib0018","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/15377903.2014.979384","article-title":"A systematic review and psychometric evaluation of adaptive behavior scales and recommendations for practice","volume":"31","author":"Floyd","year":"2015","journal-title":"J Appl School Psychol"},{"key":"10.1016\/j.seizure.2023.01.008_bib0019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ntt.2016.01.001","article-title":"Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine","volume":"54","author":"Deshmukh","year":"2016","journal-title":"Neurotoxicol Teratol"},{"issue":"1","key":"10.1016\/j.seizure.2023.01.008_bib0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.yebeh.2008.10.011","article-title":"The behavioral consequences of exposure to antiepileptic drugs in utero","volume":"14","author":"Vinten","year":"2009","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2023.01.008_bib0021","unstructured":"World Health Organisation. Child growth standards. 2013 [cited Retrieved 1 March 2020]."},{"key":"10.1016\/j.seizure.2023.01.008_bib0022","unstructured":"Royal College of Obstetricians and Gynaecologists. Small-for-gestational-age fetus, investigation and management (Green-top Guideline No.31). 2013 Retrieved 1 March 2020]."},{"key":"10.1016\/j.seizure.2023.01.008_bib0023","unstructured":"Ministries of Housing Communities and Local Government. English indices of deprivation 2019. 2019 [cited 1 March 2020."},{"key":"10.1016\/j.seizure.2023.01.008_bib0024","unstructured":"Northern Ireland Statistics and Research Agency. Northern ireland multiple deprivation measures 2017. [ Retrived March 2020]."},{"key":"10.1016\/j.seizure.2023.01.008_bib0025","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ntt.2018.11.003","article-title":"Intellectual functioning in clinically confirmed fetal valproate syndrome","volume":"71","author":"Bromley","year":"2019","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.seizure.2023.01.008_bib0026","unstructured":"British National Formulary. Topiramate: indications and dose. 2020 [Retrived 1 March 2020]."},{"issue":"6","key":"10.1016\/j.seizure.2023.01.008_bib0027","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1192\/bjp.bp.108.059345","article-title":"Prevalence of autism-spectrum conditions: UK school-based population study","volume":"194","author":"Baron-Cohen","year":"2018","journal-title":"Br J Psychiatry"},{"issue":"23","key":"10.1016\/j.seizure.2023.01.008_bib0028","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in untero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.seizure.2023.01.008_bib0029","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"16","key":"10.1016\/j.seizure.2023.01.008_bib0030","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.seizure.2023.01.008_bib0031","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1111\/epi.16953","article-title":"Neurodevelopmental outcomes in children exposed to newer antiseizure medications: a systematic review","volume":"62","author":"Knight","year":"2021","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.seizure.2023.01.008_bib0032","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/ajmg.c.30313","article-title":"Evolving knowledge of the teratogenicity of medications in human pregnancy","volume":"157","author":"Adam","year":"2011","journal-title":"Am J Med Genet Part C Semin Med Genet"},{"issue":"8","key":"10.1016\/j.seizure.2023.01.008_bib0033","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/bdra.23043","article-title":"ABCDXXX: the obscenity of postmarketing surveillance for teratogenic effects","volume":"94","author":"Friedman","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131123000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131123000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T02:03:10Z","timestamp":1761012190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131123000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":32,"alternative-id":["S1059131123000158"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2023.01.008","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adaptive behaviour in children exposed to topiramate in the womb: An observational cohort study","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2023.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd on behalf of British Epilepsy Association.","name":"copyright","label":"Copyright"}]}}